Sherry Aulin Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Sherry Aulin is Chief Financial Officer of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of XENE, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2024, when has been sold 18,709 shares (Common Shares) at a price of $41.21 per share, resulting in proceeds of $770,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

SHERRY AULIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
SELL
Open market or private sale
$770,997 $41.21 p/Share
18,709 Reduced 100.0%
0 Common Shares
Dec 18 2024
SELL
Payment of exercise price or tax liability
$273,480 $41.28 p/Share
6,625 Reduced 36.53%
11,510 Common Shares
Dec 18 2024
BUY
Exercise of conversion of derivative security
$266,260 $10.51 p/Share
25,334 Added 61.29%
16,000 Common Shares
Sep 02 2022
SELL
Payment of exercise price or tax liability
$130,172 $39.53 p/Share
3,293 Reduced 17.66%
15,355 Common Shares
Sep 02 2022
SELL
Open market or private sale
$607,597 $39.57 p/Share
15,355 Reduced 100.0%
0 Common Shares
Sep 02 2022
BUY
Exercise of conversion of derivative security
$123,823 $6.64 p/Share
18,648 Added 50.0%
18,648 Common Shares
SA

Sherry Aulin

Chief Financial Officer
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE